These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1805194)
1. Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Royer RE; Mills RG; Deck LM; Mertz GJ; Vander Jagt DL Pharmacol Res; 1991 Dec; 24(4):407-12. PubMed ID: 1805194 [TBL] [Abstract][Full Text] [Related]
2. Antiviral activities of gossypol and its derivatives against herpes simplex virus type II. Radloff RJ; Deck LM; Royer RE; Vander Jagt DL Pharmacol Res Commun; 1986 Nov; 18(11):1063-73. PubMed ID: 3025895 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the antiviral activities of 3'-azido-3'-deoxythymidine (AZT) and gossylic iminolactone (GIL) against clinical isolates of HIV-1. Royer RE; Mills RG; Young SA; Vander Jagt DL Pharmacol Res; 1995 Jan; 31(1):49-52. PubMed ID: 7540302 [TBL] [Abstract][Full Text] [Related]
4. Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol. Lin TS; Schinazi RF; Zhu J; Birks E; Carbone R; Si Y; Wu K; Huang L; Prusoff WH Biochem Pharmacol; 1993 Jul; 46(2):251-5. PubMed ID: 8347147 [TBL] [Abstract][Full Text] [Related]
5. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. An T; Ouyang W; Pan W; Guo D; Li J; Li L; Chen G; Yang J; Wu S; Tien P Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469 [TBL] [Abstract][Full Text] [Related]
6. Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. Royer RE; Deck LM; Campos NM; Hunsaker LA; Vander Jagt DL J Med Chem; 1986 Sep; 29(9):1799-801. PubMed ID: 3528492 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds. Royer RE; Deck LM; Vander Jagt TJ; Martinez FJ; Mills RG; Young SA; Vander Jagt DL J Med Chem; 1995 Jun; 38(13):2427-32. PubMed ID: 7608907 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol. Lin TS; Schinazi R; Griffith BP; August EM; Eriksson BF; Zheng DK; Huang LA; Prusoff WH Antimicrob Agents Chemother; 1989 Dec; 33(12):2149-51. PubMed ID: 2619282 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol. Bourinbaiar AS; Lee-Huang S Contraception; 1994 Feb; 49(2):131-7. PubMed ID: 7511493 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activities of novel gossypol derivatives. Yang J; Zhang F; Li J; Chen G; Wu S; Ouyang W; Pan W; Yu R; Yang J; Tien P Bioorg Med Chem Lett; 2012 Feb; 22(3):1415-20. PubMed ID: 22226654 [TBL] [Abstract][Full Text] [Related]
11. Empirical and rational approaches for development of inhibitors of the human immunodeficiency virus--HIV-1. Prusoff W; Lin TS; Pivazyan A; Sun AS; Birks E Pharmacol Ther; 1993 Nov; 60(2):315-29. PubMed ID: 8022862 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism. Yang J; Chen G; Li LL; Pan W; Zhang F; Yang J; Wu S; Tien P Bioorg Med Chem Lett; 2013 May; 23(9):2619-23. PubMed ID: 23538114 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate. Fujiwara M; Ijichi K; Tokuhisa K; Katsuura K; Shigeta S; Konno K; Wang GY; Uemura D; Yokota T; Baba M Antimicrob Agents Chemother; 1996 Jan; 40(1):271-3. PubMed ID: 8787923 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41. Yang J; Li LL; Li JR; Yang JX; Zhang F; Chen G; Yu R; Ouyang WJ; Wu SW Bioorg Med Chem Lett; 2018 Jan; 28(1):49-52. PubMed ID: 29162455 [TBL] [Abstract][Full Text] [Related]
15. Binding of gossypol derivatives to human serum albumin. Royer RE; Kibirige M; Tafoya CR; Deck LM; Vander Jagt DL J Pharm Sci; 1988 Mar; 77(3):237-40. PubMed ID: 3373428 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz. Prochaska HJ; Bornmann WG; Baron P; Polsky B Mol Pharmacol; 1995 Jul; 48(1):15-20. PubMed ID: 7542738 [TBL] [Abstract][Full Text] [Related]
18. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936 [TBL] [Abstract][Full Text] [Related]
19. The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum. Dando C; Schroeder ER; Hunsaker LA; Deck LM; Royer RE; Zhou X; Parmley SF; Vander Jagt DL Mol Biochem Parasitol; 2001 Nov; 118(1):23-32. PubMed ID: 11704270 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+. Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]